The role of fluconazole in the treatment of candida endocarditis: A meta-analysis

Medicine

Volumn 90, Issue 4, 2011, Pages 237-249

  Smego Jr , Raymond A ^a   Ahmad, Hassan ^a  

^a Janet Weis Children s Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; CEFTRIAXONE; FLUCONAZOLE; FLUCYTOSINE; GENTAMICIN; MICONAZOLE; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; CANDIDA ENDOCARDITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART VALVE REPLACEMENT; HEART VALVE SURGERY; HUMAN; LOADING DRUG DOSE; MALE; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTHETIC VALVE ENDOCARDITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDEMIA; CANDIDIASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOCARDITIS; FEMALE; FLUCONAZOLE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 79959793002     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e3182259d38     Document Type: Article

References (94)

1. Aaron L, Therby A, Viard JP, Lahoulou R, Dupont B. Successful medical treatment of Candida albicans in mechanical prosthetic valve endocarditis. Scand J Infect Dis. 2003;35:351-352. (Pubitemid 36889337)
2. Ariffin H, Ariffin W, Tharam S, Omar A, de Bruyne J, Lin HP. Successful treatment of Candida albicans endocarditis in a child with leukemiaVa case report and review of the literature. Singapore Med J. 1999;40:533-536. (Pubitemid 29441148)
3. Aspesberro F, Beghetti M, Oberhansli I, Friedli B. Fungal endocarditis in critically ill children. Eur J Pediatr. 1999;158:275-280. (Pubitemid 29183700)
4. Bacak V, Biocina B, Starcevic B, Gertler S, Begovac J. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient-case report and review of the literature. J Infect. 2006;53:11-14.
5. Baddley JW, Benjamin DK Jr, Patel M, Miro J, Athan E, Barsic B, Bouza E, Clara L, Elliott T, Kanafani Z, Klein J, Lerakis S, Levine D, Spelman D, Rubinstein E, Tornos P, Morris AJ, Pappas P, Fowler VG Jr, Chu VH, Cabell C; International Collaboration on Endocarditis-Prospective Cohort Study Group (ICE-PCS). Candida infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008;27:519-529.
6. Baddour LM. Long-term suppressive therapy for Candida parapsilosis-induced prosthetic valve endocarditis. Mayo Clin Proc. 1995;70:773-775.
7. Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis. 2006;10;6:21.
8. Bayer AS, Witt MD, Kim E, Ghannoum MA. Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. Antimicrob Agents Chemother. 1996;40:494-496. (Pubitemid 26049368)
9. Bernard E, Caries M, Toussaint-Gari M, Fournier JP, Dellamonica P. Value of fluconazole in the treatment of systemic yeast infection. Pathol Biol. 1989;37:690-693. (Pubitemid 19170929)
10. Bodey GP, Anaissie EJ. Fluconazole versus intravenous amphotericin B for antifungal prophylaxis in leukemia patients. 17th International Congress of Chemotherapy. Berlin: Federal Republic of Germany; 1991.
11. Cancelas JA, Lopez J, Cabezudo E, Navas E, Garcia Larana J, Jimenez Mena M, Diz P, Perez de Oteyza J, Villalon L, Sanchez-Sousa A. Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia. Bone Marrow Transplant. 1994;13:333-334. (Pubitemid 24065962)
12. Castiglia M, Smego RA Jr, Sames EL. Candida endocarditis and amphotericin B intolerance: potential role for fluconazole. Infect Dis Clin Prac. 1994;3:248-253. (Pubitemid 24251902)
13. Chemlal K, Saint-Julien L, Joly V, Farinotti R, Seta N, Yeni P, Carbon C. Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. Antimicrob Agents Chemother. 1996;40:263-266. (Pubitemid 26019711)
14. Czwerciec FS, Bilsker MS, Kamerman ML, Bisno AL. Long-term survival after fluconazole of Candidal prosthetic valve endocarditis. Am J Med. 1993;94:545-546. (Pubitemid 23142971)
15. Daas H, Abuhmaid F, Zervos M. Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report. J Med Case Reports. 2009;3:6598.
16. Daftary AS, Patole SK, Whitehall JS. Intracardiac fungal masses in high-risk neonates: clinical observations. Acta Paediatr. 1999;88:1009-1013. (Pubitemid 29448268)
17. Darwazah A, Berg G, Faris B. Candida parapsilosis: an unusual organism causing prosthetic heart valve infective endocarditis. J Infect. 1999;38:130-131. (Pubitemid 29229642)
18. del Castillo M, Wainsztein N, Klein F, Manganello S, Orellana N. ETreatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazole.^ Medicina (B Aires). 2004;64:152-154. (Pubitemid 39199696)
19. Deng G, Wang A. ERetrospective analysis of 15 patients with fungal septicaemia.^ Zhonghua Nei Ke Za Zhi. 2001;40:594-596.
20. Divekar A, Rebekya IM, Soni R. Late onset Candida parapsilosis endocarditis after surviving nosocomial candidemia in an infant with structural heart disease. Pediatr Infect Dis J. 2004;23:472-475. (Pubitemid 38621492)
21. du Plessis FA, Helbing WA, Bogers AJ. Excision of the tricuspid valve in a baby with Candida endocarditis. Cardiol Young. 2007;17:545-547. (Pubitemid 350065553)
22. Edwards JE Jr. Candida species (Chapter 257). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone/Elsevier; 2010.
23. Falcone M, Barzaghi N, Carosi G, Grossi P, Minoli L, Ravasio V, Rizzi M, Suter F, Utili R, Viscoli C, Venditti M. Italian Study on Endocarditis. Candida infective endocarditis: report of 15 cases from a prospective multicenter study. Medicine (Baltimore). 2009;88:160-168.
24. Fischer SA, Trenholme GM, Costanzo MR, Piccione W. Infectious complications in left ventricular assist device recipients. Clin Infect Dis. 1997;24:18-23. (Pubitemid 27023667)
25. Fowler V Jr, Scheld WM, Bayer AS. Endocarditis and intravascular infections (Chapter 77). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone/Elsevier; 2010.
26. Galgiani JN, Stevens DA. Fungal endocarditis: need for guidelines in evaluating therapy. J Thorac Cardiovasc Surg. 1997;73:293-296.
27. Gilbert HM, Peters ED, Lang SJ, Hartman BJ. Successful treatment of fungal prosthetic valve endocarditis: case report and review. Clin Infect Dis. 1996;22:348-354. (Pubitemid 26056167)
28. Girmenia C, Martino P, De Bernardis F, Gentile G, Boccanera M, Monaco M, Antonucci G, Cassone A. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis. 1996;23:506-514. (Pubitemid 26304499)
29. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992; 326:845-851.
30. Gullu AU, Akcar M, Arnaz A, Kizilay M. Candida parapsilosis tricuspid native valve endocarditis: 3-year follow-up after surgical treatment. Interact Cardiovasc Thorac Surg. 2008;7:513-514. (Pubitemid 351769106)
31. Hariya A, Naruse Y, Kobayashi T, Endo M, Ikeda Y, Yoshii T, Momomura S, Ishiwata S, Maehara A. EFungal endocarditis found at onset of lower limb acute aortic occlusion; report of a case.^ Kyobu Geka. 2005;58:831-834.
32. Hartyánszky IL, Pintér M, Kádár K, Oprea V, Krause I, Lozsádi K. Candida endocarditis in an infant. Pediatr Cardiol. 1997; 18:440-442. (Pubitemid 27449478)
33. Hernandez JA, Gonzalez-Moreno M, Llibre JM, Aloy A, Casan CM. Candidal mitral endocarditis and long-term treatment with fluconazole in a patient with human immunodeficiency virus infection. Clin Infect Dis. 1992;15:1062-1063.
34. Inoue Y, Yozu R, Ueda T, Kawada S. A case report of Candida parapsilosis endocarditis. J Heart Valve Dis. 1998;7:240-242. (Pubitemid 28168505)
35. Isalska BJ, Stanbridge TN. Fluconazole in the treatment of Candidal prosthetic valve endocarditis. Br Med J. 1988;297:178-179.
36. Johnston PG, Lee J, Domanski M, Dressler F, Tucker E, Rothenberg M, Cunnion RE, Pizzo PA, Walsh TJ. Late recurrent Candida endocarditis. Chest. 1991;99:1531-1533.
37. Joly V, Carbon C. Unfortunate in vitro selection of resistant Candida albicans with severe clinical consequences. Clin Infect Dis. 1998;27:692-694. (Pubitemid 29244318)
38. Jones JM, Sarsam MA, Clarke MA, Hedderwick SA. Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve. J Infect. 2002;44:196-198. (Pubitemid 36104776)
39. Kaloterakis A, Rizos I, Goumas G, Filiotou A, Barbetseas J, Papathanasiou S, Toutouzas P. Isolated native tricuspid valve Candida endocarditis in a non-drug-addicted patient: case report and review of the literature. J Heart Valve Dis. 2003;12:652-658. (Pubitemid 37185185)
40. Kan CD, Luo CY, Lin PY, Yang YJ. Native-valve endocarditis due to Candida parapsilosis. Interact Cardiovasc Thorac Surg. 2002;1:66-68.
41. Karatza AA, Dimitriou G, Marangos M, Christofidou M, Pavlou V, Giannakopoulos I, Darzentas A, Mantagos SP. Successful resolution of cardiac mycetomas by combined liposomal amphotericin B with fluconazole treatment in premature neonates. Eur J Pediatr. 2008;167:1021-1023.
42. Khan MU, Ali S, Baig MA, Rafiq MA, Vasavada BC, Khan IA. Candida parapsilosis endocarditis 8 months after transient candidemia. Int J Cardiol. 2007;118:e58Ye59. (Pubitemid 46601677)
43. Kindel M, Sternfeldt R, Spiller P. ECandida albicans endocarditis with mycotic aneurysms of the lower leg arteries in a patient with mechanical heart valve prosthesis.^ Z Kardiol. 2002;91:715-718.
44. Kurata H, Ozaki T, Kase M, Nakayama H, Nakamura N, Ichikawa Y, Kondo J, Matsumoto A. EA case of endocarditis caused by Candida glabrata.^ Kyobu Geka. 1993;46:866-869.
45. Lejko-Zupanc T, Kozelj M. A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone. J Infect. 1997;35:81-82. (Pubitemid 27380043)
46. Levy I, Shalit I, Birk E, Sirota L, Ashkenazi S, German B, Linder N. Candida endocarditis in neonates: report of five cases and review of the literature. Mycoses. 2006;49:43-48.
47. Longman LP, Hibbert SA, Martin MV. Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis. Rev Infect Dis. 1990;12(Suppl 3):S294YS298. (Pubitemid 20125724)
48. Lopez-Ciudad V, Castro-Orjales MJ, Leon C, Sanz-Rodriguez C, de la Torre-Fernandez MJ, Perez de Juan-Romero MA, Collell-Llach MD, Diaz-Lopez MD. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. BMC Infect Dis. 2006;6:73.
49. Louie A, Kaw P, Banerjee P, Liu W, Chen G, Miller MH. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. Antimicrob Agents Chemother. 2001;45:485-494. (Pubitemid 32105285)
50. Louie A, Liu W, Miller DA, Sucke AC, Liu QF, Drusano GL, et al. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans. Antimicrob Agents Chemother. 1999;43:2831-2840.
51. Lye DC, Hughes A, O'brien D, Athan E. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbiol Infect Dis. 2005;9:1-3.
52. Malani AN, Aronoff DM. Voriconazole-induced photosensitivity. Clin Med Res. 2008;6:83-85.
53. Marti J. Candida parapsilosis endocarditis in aged patient. Eur J Intern Med. 2009;20:e15.
54. Martino P, Meloni G, Cassone A. Candidal endocarditis and treatment with fluconazole and granulocyte-macrophage colony-stimulating factor. Ann Intern Med. 1990;112:966-967. (Pubitemid 20193692)
55. Mathew R, Ranjit MS, Rajamani MR. Postoperative endocarditis due to Candida tropicalis. J Assoc Physicians India. 1999;47:921-922.
56. Melgar GR, Nasser RM, Gordon SM, Lytle BW, Keys TF, Longworth DL. Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital. Medicine (Baltimore). 1997;76:94-103. (Pubitemid 27157664)
57. Minette MS, Ibsen LM. Survival of Candida sepsis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2005;6:709-711. (Pubitemid 41642555)
58. Mogyorosy G, Sobs G, Nagy A. Candida endocarditis in a premature infant. J Perinat Med. 2000;28:407-411. (Pubitemid 32952983)
59. Moudgal V, Little T, Boikov D, Vazquez JA. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob Agents Chemother. 2005;49:767-769. (Pubitemid 40175691)
60. Nguyen MH, Nguyen ML, Yu VL, McMahon D, Keys TF, Amidi M. Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. Clin Infect Dis. 1996;22:262-267. (Pubitemid 26056154)
61. Nishida T, Mayumi H, Kawachi Y, Tokunaga S, Maruyama Y, Nakashima A, Yasui H, Tokunaga K. The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. Surg Today. 1994;24:651-654. (Pubitemid 24229317)
62. Noguchi M, Takai H, Eishi K, Atogami S. Prosthetic valve endocarditis due to Candida albicans treated successfully with medical treatment alone. Jpn J Thorac Cardiovasc Surg. 2004;52:318-321. (Pubitemid 38855936)
63. Odds FC, Cheesman SL, Abbott AB. Antifungal effects of fluconazole (UK 9858), a new triazole antifungal, in vitro. J Antimicrob Chemother. 1986;18:473-478. (Pubitemid 16030724)
64. Otaki M, Kitamura N. Candida prosthetic valve endocarditis. An autopsy review. Int Surg. 1993;78:252-253. (Pubitemid 23300639)
65. Penk A, Pittrow L. Role of fluconazole in the long-term suppressive therapy of fungal infections in patients with artificial implants. Mycoses. 1999;42(Suppl 2):91-96. (Pubitemid 30253118)
66. Perfect JR, Wright KA, Hobbs MM, Durack DT. Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. Antimicrob Agents Chemother. 1989; 33:1735-1740. (Pubitemid 19239166)
67. Pinar D, Reus S, Perez P, Quiles JA. EConservative management with new antifungals in a case of Candida prosthetic valve endocarditis.^ Enferm Infecc Microbiol Clin. 2010;28:66-67.
68. Prabhu RM, Orenstein R. Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis. Clin Infect Dis. 2004;39:1253-1254. (Pubitemid 40169330)
69. Presterl E, Daxbock F, Graninger W, Willinger B. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clin Microbiol Infect. 2007;13:1072-1076. (Pubitemid 47543107)
70. Reyes MP, Ali A, Mendes RE, Biedenbach DJ. Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008. Medicine (Baltimore). 2009;88:294-301.
71. Roel JE, Gamba A, Curone M, Pescio A, Bruno C, Finquelievich J. ESuccessful medical treatment of Candida tropicalis in prosthetic valve endocarditis.^ Medicina (B Aires). 1998;58:301-302. (Pubitemid 28334580)
72. Roger PM, Boissy C, Gari-Toussaint M, Foucher R, Mondain V, Vandenbos F, le Fichoux Y, Michiels JF, Dellamonica P. Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata. J Infect. 2000;41:176-178.
73. Roupie E, Darmon JY, Brochard L, Saada M, Rekik N, Brun-Buisson C. Fluconazole therapy of Candidal native valve endocarditis. Eur J Clin Microbiol Infect Dis. 1991;10:458-459.
74. Saito Y, Takahashi M, Sato A, Katsuki T, Ikeda U, Shimada K. Isolated tricuspid valve endocarditis due to Candida parapsilosis-associated with long-term central venous catheter implantation. Intern Med. 2001;40:403-404. (Pubitemid 33664509)
75. Salamon SA, Fuursted K, Egeblad H, Petersen E, Ott P. Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery. Scand J Infect Dis. 2007;397:641-644. (Pubitemid 47009185)
76. Sanati H, Ramos CF, Bayer AS, Ghannoum MA. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective endocarditis rabbit models. Antimicrob Agents Chemother. 1997;41:1345-1348. (Pubitemid 27231439)
77. Senba M, Watanabe K, Yoshida K, Ochi S, Matsumoto K, Yano K, Itakura H. Endocarditis caused by Candida parapsilosis. Southeast Asian J Trop Med Public Health. 1992;23:138-141.
78. Talvard M, Paranon S, Dulac Y, Mansir T, Kreitmann B, Acar P. Candida albicans endocarditis after pulmonary artery banding. Arch Pediatr. 2009;16:1146-1149.
79. Thakur RK, Skelcy KM, Kahn RN, Cannon L, Cherukuri R. Successful treatment of Candida prosthetic valve endocarditis with a combination of fluconazole and amphotericin B. Crit Care Med. 1994;22:712-714. (Pubitemid 24121576)
80. Tonomo K, Tsujino T, Fujioka Y, Nakao S, Yao H, Yasoshima H, Kubota A, Iwasaki T, Ohyanagi M. Candida parapsilosis endocarditis that emerged two years after abdominal surgery. Heart Vessels. 2004;19:149-152. (Pubitemid 38842528)
81. Venditti M, De Bernardis F, Micozzi A, Pontieri E, Chirletti P, Cassone A, Martino P. Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated endophthalmiitis and folliculitis. Clin Infect Dis. 1992;14:422-426.
82. Veraldi GF, Guglielmi A, Genna M, Bertolini P, Pasetto E, Dusi R, Cordiano C. Occlusion of the common iliac artery secondary of fungal endocarditis: report of a case. Surg Today. 2000;30:291-293. (Pubitemid 30187226)
83. Wallbridge DR, McCartney AC, Richardson MD. Fluconazole in the treatment of Candida prosthetic valve endocarditis. Mycoses. 1993;36:259-261. (Pubitemid 23355091)
84. Walsh TJ, Foulds G, Pizzo PA. Pharmacokinetics and tissue penetration of fluconazole in rabbits. Antimicrob Agents Chemother. 1989;33:467-469. (Pubitemid 19094274)
85. Wells CJ, Leech GJ, Lever AM, Wansbrough-Jones MH. Treatment of native valve Candida endocarditis with fluconazole. J Infect. 1995;31:233-235.
86. Wendt B, Haglund L, Razavi A, Rath R. Candida lusitaniae: an uncommon cause of prosthetic valve endocarditis. Clin Infect Dis. 1998;26:769-770. (Pubitemid 28155045)
87. Westling K, Thalme A, Julander I. Candida albicans tricuspid valve endocarditis in an intravenous drug addict: Successful treatment with fluconazole. Scand J Infect Dis. 2005;37:310-311. (Pubitemid 40542782)
88. Witt MD, Bayer AS. Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis. Antimicrob Agents Chemother. 1991;35:2481-2485.
89. Witt MD, Imhoff T, Li C, Bayer AS. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. Antimicrob Agents Chemother. 1993;37:2030-2032. (Pubitemid 23265577)
90. Yamamoto W, Ino T, Sakurabayashi I, Ide H, Yaginuma T. EA case of Candida albicans endocarditis with impaired lung function.^ Kansenshogaku Zasshi. 1992;66:536-539.
91. Yap KB, Low ST. Successful treatment of Candida albicans endocarditits in a child with leukemia: a case report and review of the literature. Singapore Med J. 1999;40:533-536.
92. Yates AB, Mehrotra D, Moffitt JE. Candida endocarditis in a child with immunoglobulin E syndrome. J Allergy Clin Immunol. 1997;99:770-772. (Pubitemid 27280367)
93. Yeaman MR, Cheng D, Desai B, Kupferwasser LI, Xiong YQ, Gank KD, Edwards JE Jr, Bayer AS. Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans. Antimicrob Agents Chemother. 2004;48:3051-3056. (Pubitemid 38989174)
94. Zahid MA, Klotz SA, Hinthorn DR. Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. Chest. 1994;105:1597-1598. (Pubitemid 24152639)